Network meta-analysis of ketamine regimens for pediatric ED procedural sedation safety and efficacy
This network meta-analysis assessed the safety and efficacy of various ketamine-based regimens compared to IV ketamine for sedating pediatric patients during painful emergency department procedures. The analysis synthesized data from 24 randomized controlled trials to compare outcomes across different administration routes and adjunctive medications.
Results indicate that intramuscular ketamine is associated with longer sedation duration compared to IV ketamine, with a mean difference of +19.6 minutes (95% CI 17.5-21.6). Recovery time is also extended with intramuscular administration, showing a mean difference of +37.7 minutes (95% CI 1.6-73.8). When atropine is added to intramuscular ketamine, recovery time increases further by a mean difference of +73.5 minutes (95% CI 10.9-136.1).
Regarding adverse events, the combination of IV ketamine and midazolam significantly raised the risk of hypoxia, with a relative risk of 4.71 (95% CI 1.05-21.08). Conversely, adding propofol to IV ketamine reduced the risk of nausea, with a relative risk of 0.34 (95% CI 0.17-0.68). Intramuscular ketamine also demonstrated a lower risk of emergence reactions compared to IV ketamine, with a relative risk of 0.38 (95% CI 0.20-0.69).
The authors note that follow-up duration was not reported for the included studies. Serious adverse events, discontinuations, and overall tolerability were not reported in the source data. While the network meta-analysis provides comparative insights, the absence of reported follow-up and specific safety metrics limits the ability to fully assess long-term outcomes or rare adverse events in this pediatric population.